Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
…
continue reading
1
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physic ...
…
continue reading
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is Chief of Clinical Trials, Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Centre Tom Powles is Director of Barts Cancer Centre, St Bartholomews Hospital and Professor or Genitourinary oncology, Queen Mary University of London
…
continue reading
1
PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
PVI, PeerView Institute for Medical Education
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
Designed for residents and fellows to provide an overview of the clinical practice and evidence behind management of each individual tumor site. Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, cancer
…
continue reading
An academic platform for discussion of the latest and greatest updates in the ever evolving field of Medical Oncology and Clinical Hematology. Contact prashant.jambunathan@gmail.com
…
continue reading
learn bite-sized information about different aspects of hematology and oncology.
…
continue reading
The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.
…
continue reading
Interviews with experts on the top news and controversies in the field of oncology today.
…
continue reading
Oncology and hematology
…
continue reading
MedEdTalks Hematology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. The intended audience for this series is hematologists, hematology nurses (RNs) and nurse practitioners (NPs), oncology RNs, oncology NPs, hemophilia treatment center RNs, hemophilia treatment center NPs, and other health care professionals.
…
continue reading
Dr RR Baliga's 'Got Knowledge Doc?' Podcasts for Physicians and Physician Extenders. Not medical advice or medical opinion www.MasterMedFacts.com
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in renal cell carcinoma.
…
continue reading
Sundays @ 9:30am on KMA 960 AM - Shenandoah, IA
…
continue reading
Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating ...
…
continue reading
1
JOWMA (Jewish Orthodox Women's Medical Association) Podcast
JEWISH ORTHODOX WOMEN’S MEDICAL ASSOCIATION
Jennie Berkovich, DO and Alisa Minkin, MD host JOWMA's podcast and share preventative health information geared to members of the Orthodox Jewish community.
…
continue reading
Most people don’t know that you’re considered a cancer survivor at the moment of diagnosis. It wasn’t always this way. Sixty years ago, a cancer diagnosis was a death sentence. And if you did survive, you were left to figure out the rest of your life on your own. But some survivors demanded something different, something better. This is The Cancer Mavericks, a deep-dive narrative into the people who fought for better treatment, forced doctors to listen, and pushed America to see the human si ...
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational reso ...
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
This book and subsequent audio companion reflect what I would have wanted when I was studying for the USMLE Step 2 CK exam. One of the major hurdles I faced while studying for my exam was the lack of a single reference resource similar to what existed for the USMLE Step 1 exam at the time of writing this book. This meant I had to use multiple resources which presented information in different formats and with different points of emphasis, resulting in a disorganized study approach. Despite m ...
…
continue reading
Welcome to Kars and Koaching, the podcast where we seamlessly blend our passion for cars, the intricacies of medicine, and the art of self-development to guide you towards the life you truly deserve. Join us on this unique journey as we explore the intersections of automotive excellence, healthcare insights, and personal growth. Get ready for engaging conversations, expert interviews, and practical tips that rev up your life both on and off the road. It's not just about driving, healing, or ...
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
Frederick Health presents Coffee with Cookie: A Podcast Focused on Your Health & Happiness. Taking care of yourself, making healthy choices, and focusing on overall wellness can feel like a complex topic, but it doesn’t have to be. Join us as we take a deeper dive into the world of healthcare, disease prevention, wellness, and more. Brought to you by healthcare experts and providers that see patients right here in Frederick County. Frederick Health is simplifying the world of healthcare—beca ...
…
continue reading
1
Sara M. Tolaney, MD, MPH - Critically Focusing Decision-Making and Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC
1:05:37
1:05:37
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:05:37
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading
1
Hope S. Rugo, MD, FASCO - Exchanging Ideas on How to Navigate Patient-Centric Clinical Decisions in Integration of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
1:16:56
1:16:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:16:56
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/T…
…
continue reading
1
Chapter 9: Hematology-Oncology - Miscellaneous Oncology
12:03
12:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:03
We conclude this chapter discussing oncologic syndromes, paraneoplastic associations, and review of screening guidelines.Par Abdillahi Omar, M.D.
…
continue reading
1
Episode 345: ESMO 2024 - SUNNIFORECAST: Ipi/Nivo vs SOC in Non-clear Cell RCC
31:10
31:10
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:10
Lothar Bergmann describes this investigator-initiated trial of Ipi/Nivo vs SOC in Non-clear Cell RCC
…
continue reading
1
Episode 344: ESMO 2024 - NKT2152, a HIF inhibitor in RCC
22:32
22:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:32
Brad McGregor joins Brian and Tom to discuss a new HIF inhibitor, NKT2152, and preliminary data in RCC
…
continue reading
1
Episode 343: ESMO 2024 - TiNivo-2 Trial
31:23
31:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:23
Katy Beckermann discusses the TiNivo-2 study presented at ESMO 2024.
…
continue reading
1
CD8+ T-cell differentiation and treatment response in AML; ATM germline pathogenic variants affect cancer outcomes in ataxia-telangiectasia; efficacy of a selective menin-KMT2A inhibitor in KMT2A- and ...
22:42
22:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:42
In this week's episode we’ll discuss how CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia; learn more about the effect of ATM germline pathogenic variants on the outcomes in children with ataxia-telangiectasia and hematological malignancies; and discuss the preclinical efficacy of a potent, selective m…
…
continue reading
1
Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
2:03:22
2:03:22
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
2:03:22
Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates …
…
continue reading
1
Avoiding the Trauma Bay with Anna Goldenberg, DO
26:24
26:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
26:24
Dr. Goldenberg is a trauma and acute care surgeon at Cooper University Trauma center, a busy urban Level I adult and Level II pediatric trauma center in Camden NJ. With a strong educational background, she completed her surgical training at UMDNJ and further honed her expertise through a trauma and critical care fellowship in 2015 at Cooper Univers…
…
continue reading
This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future episodes. Episode contents: - What is CHIP vs. CCUS vs. ICUS? - What is t…
…
continue reading
1
Global perspectives on blood cancers: addressing disparities in awareness, diagnosis, and treatment
18:54
18:54
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:54
Welcome to the first episode of VJHemOnc's Blood Cancer Awareness Month special series! This episode focuses on global perspectives of blood cancers and addresses the disparities that exist in awareness, diagnosis, and treatment. First, Lalit Kumar, MD, MBBS, Artemis Hospital, New Delhi, India, discusses challenges that exist in the management of b…
…
continue reading
1
S1 Ep126: Improving Quality of Life in Cancer With Physical Medicine & Rehabilitation
18:53
18:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:53
In a conversation with CancerNetwork®, Jessica Cheng, MD, spoke about her work in the growing field of physical medicine and rehabilitation (PMR) and how it may improve quality of life outcomes among patients with cancer. Above all else, Cheng, an assistant clinical professor in the Department of Supportive Care Medicine at City of Hope, emphasized…
…
continue reading
1
Heme & Onc Fellow Board Review Tips 2024
16:03
16:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:03
This week’s episode will be focusing on final board review tips. We will go over our highest yield cheat sheet topics, and how we prepared the days leading up to our exam. We took our boards three years ago now, but the stress leading up to the exam is certainly fresh in our minds.
…
continue reading
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joshua E. Reuss, MD The phase 2 ICARUS-Lung01 study evaluated not only the efficacy and safety of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), but also potential biomarkers associated with response and/or resistance. Here to discuss…
…
continue reading
1
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
1:02:34
1:02:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:02:34
Prof Peter Schmid from the Barts Cancer Institute in London, United Kingdom, and Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, review clinical trials investigating the role of antibody-drug conjugate-mediated therapies in the treatment of metastatic breast cancer.Par Neil Love, MD
…
continue reading
1
Sara M. Tolaney, MD, MPH - Critically Focusing Decision-Making and Communication Strategies to Reduce Recurrence in High-Risk HR+, HER2- EBC
1:05:37
1:05:37
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:05:37
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…
…
continue reading
1
Hope S. Rugo, MD, FASCO - Exchanging Ideas on How to Navigate Patient-Centric Clinical Decisions in Integration of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
1:16:56
1:16:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:16:56
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/T…
…
continue reading
1
Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC
13:53
13:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:53
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for second-line and beyond treatments in patients with recurrent ROS1-altered advanced NSCLC including: Assessing ROS1-TKI resistance mutations with tumor and liquid biopsies in patients with ROS1-altered advan…
…
continue reading
1
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC
13:46
13:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:46
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontline treatments for ROS1-altered NSCLC including: Efficacy and safety data for crizotinib, entrectinib, and repotrectinib in patients with ROS1-altered advanced NSCLC Long-term safety observations for cri…
…
continue reading
1
TCR-T cells for post-HCT leukemia recurrence; platelets are the predominant source of procoagulant membranes in hemostasis; BR + R maintenance for MCL
18:10
18:10
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:10
In this week's episode we'll discuss HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation. Next, we'll learn about how 4D intravital imaging in mice reveals the key role of platelets as a source of procoagulant membranes in hemostasis. Finally, we'll hear about modifications to a common i…
…
continue reading
1
Specialty Spotlight: Alan Rozanski, MD, Nuclear Medicine/Cardiology
32:15
32:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:15
Dr. Alan Rozanski is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Chief Academic Officer, Executive Director of Cardiac Education and Fellowship Training Programs, and Director of Nuclear Cardiology for the Department of Cardiology at Mount Sinai St. Lukes. A graduate of Yale University and the Tufts University School o…
…
continue reading
By popular demand, our next series that we are excited to share with you is on MDS/AML! As we prepare for the release of the first episode next week, let’s throw it back to Episode 019 in our Heme/Onc Emergencies Series and talk about APL! Episode contents: - How do we diagnose APL? - What are characteristic findings of APL? - What is the acute man…
…
continue reading
1
Episode 342: ESMO 2024 Preview with Silke Gillessen
32:24
32:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:24
Silke joins Brian and Tom to discuss upcoming data in prostate, bladder and kidney cancer in Barcelona at ESMO 2024
…
continue reading
1
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
18:21
18:21
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:21
In a special co-branded episode between Oncology On the Go and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, Rahul Banerjee, MD, FACP, and Noopur Raje, MD, discussed the risk of secondary malignancies in patients with multiple myeloma who receive CAR T-cell therapy. Banerjee is an assistant professor i…
…
continue reading
1
Insights into PV and ET: treating the AYA population, defining goals when treating patients, & more
11:50
11:50
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:50
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPNs) characterized by the overproduction of red blood cells and platelets, respectively, due to mutations in hematopoietic stem cells. In this podcast, experts Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL; Lucia Masarova, MD, The University of Te…
…
continue reading
1
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
1:15:58
1:15:58
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:15:58
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, discusses recent advances in the treatment of breast cancer following the 2024 ASCO Annual Meeting.Par Neil Love, MD
…
continue reading
1
Outcomes of younger patients with mantle cell lymphoma; M-protein assessment during maintenance therapy in multiple myeloma; in vivo CAR T-cell generation using lentiviral vectors
0:59
In this week's episode we’ll discuss the outcomes of younger patients with mantle cell lymphoma experiencing late relapse; learn more about mass spectrometry-based assessment of M-protein in peripheral blood during maintenance therapy in multiple myeloma and discuss in vivo CAR T-cell generation in non-human primates using lentiviral vectors. Featu…
…
continue reading
Introduced by Associate Editor Dr. Thomas Ortel, this bonus episode discusses the Review Series on Factor XI, published in volume 143 issue 15 of Blood Journal. Dr. Ortel is joined by contributing authors Owen McCarty, PhD, Gili Kenet, MD, and David Gailani, MD. Review Series Articles: Introduction to a review series on factor XI Biology of factor …
…
continue reading
1
The Needs of Gifted Students: Misdiagnosed & Misunderstood Exceptional Learners with Pessy Sloan, PhD
31:39
31:39
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:39
Pessy J. Sloan is an Associate Professor in the College of Arts, Sciences and Education of Daemen University. Dr. Sloan earned her Ph.D. in Clinical and School Psychology from Hofstra University in 2000. She teaches graduate courses in both early childhood and childhood special education. Prior to joining Daemen University, Dr. Sloan held various t…
…
continue reading
1
Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
35:53
35:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:53
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC cre…
…
continue reading
1
Bradley J. Monk, MD, FACS, FACOG - Advancing Immunotherapy: Revolutionizing Cervical Cancer Treatment
35:53
35:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:53
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/YQP865. CME/MOC cre…
…
continue reading
1
ROS1-Alterations and Molecular Testing in Advanced NSCLC
16:28
16:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:28
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …
…
continue reading
1
Christopher L. Moertel, MD - Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas
37:22
37:22
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:22
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA c…
…
continue reading
1
Christopher L. Moertel, MD - Mapping a New Treatment Journey in NF1: New Developments With MEKi for Pediatric and Adult Patients With NF1-Plexiform Neurofibromas
37:22
37:22
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:22
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/DET865. CME/AAPA c…
…
continue reading
1
Episode 341: Hormone Resistance in Prostate Cancer
33:05
33:05
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
33:05
Nima Sharifi joins Brian and Tom to discuss mechanisms of resistance to hormone therapy in prostate cancer
…
continue reading
1
Palliative Care x Dr. Janet Abrahm Part 1
27:44
27:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
27:44
In Part 1 we discuss how to explain palliative care to patients, pain and anti-emetic management, non-pharmacologic strategies, and current innovations within palliative care. We are so honored to have Dr. Janet Abrahm here with us who is a national leader in the field of palliative care and a professor at Harvard Medical School.…
…
continue reading
1
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
11:56
11:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
11:56
In a conversation with CancerNetwork®, Brian A. Van Tine, MD, PhD, spoke about the FDA accelerated approval of afamitresgene autoleucel (afami-cel; Tecelra) for patients with metastatic or unresectable synovial sarcoma expressing MAGE-A4. He discussed the data from the phase 2 SPEARHEAD-1 trial (NCT04044768) supporting the agent’s use in this patie…
…
continue reading
1
Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
46:12
46:12
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
46:12
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer.Par Neil Love, MD
…
continue reading
1
Protective role of neonatal CMV infection in B-ALL; GVHD targets organoid-forming bile duct stem cells; seven-year outcomes for venetoclax-ibrutinib therapy in MCL
16:56
16:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:56
In this week's episode we'll learn how cytomegalovirus infection early in life depletes preleukemic cells in a mouse model of B-cell acute lymphoblastic leukemia. After that we'll discuss new research, where GVHD targets organoid-forming bile duct stem cells in a TGF-beta-dependent manner. Conversely, a TGF-beta inhibitor protects these stem cells …
…
continue reading
1
From Fear to Freedom: Attacking Allergies with Zoya Treyster, MD
38:36
38:36
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
38:36
Zoya Treyster, who is board-certified in both Pediatrics and Allergy/Immunology, works at Uptown Pediatrics in NYC. Dr. Treyster completed her undergraduate and medical school training at George Washington University, her pediatric residency at New York-Presbyterian Columbia, and her fellowship in Allergy/Immunology at Hofstra Northwell. Prior to j…
…
continue reading
A brief discussion of gout, pseudogout, and synovial fluid analysis.Par Abdillahi Omar, M.D.
…
continue reading
1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:23
1:01:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting.Par Neil Love, MD
…
continue reading
1
Episode 113: Sickle Cell Series - “Double Duty: A Doctor's Story of Living with Sickle Cell Disease While Caring for Others”
This week, we have an INCREDIBLE episode for you. We welcome Titilope Fasipe, MD, PhD, who not only is the Co-Director of the Sickle Cell and Thalassemia Program at Texas Children’s and an Assistant Professor in the Department of Pediatrics at the Baylor College of Medicine, she herself also has sickle cell disease! Dr. Fasipe takes us through her …
…
continue reading
Review of seronegative spondyloarthropathies.Par Abdillahi Omar, M.D.
…
continue reading
1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
18:41
18:41
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:41
This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…
…
continue reading
1
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
10:56
10:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:56
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles H…
…
continue reading